
Eclevar
Information
Eclevar MedTech, a Paris-based CRO founded in 2020, has quickly gained recognition for its comprehensive services spanning pre-market clinical trials and post-market clinical follow-up (PMCF). What truly sets Eclevar apart is its innovative platform, Milo, designed specifically for the MedTech industry. Milo streamlines site feasibility and qualification, accelerates patient identification, and integrates state-of-the-art eCOA/ePRO solutions. Leveraging an international team of experts, Eclevar provides cutting-edge, tech-enabled services to help MedTech companies navigate the clinical challenges posed by MDR 2017/745, making it a trusted partner in advancing medical innovation.
